Cynthia Donovan, a registered New York dietitian, embarked on a pre-wedding trend followed by millions of brides, but soon ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Shares of Novo Nordisk (NYSE: NVO) are tumbling on Monday, down 5.6% as of 2:11 p.m. ET. The drop comes as the S&P 500 ...

Once-monthly maridebart cafraglutide resulted to significant weight loss at 1 year among adults with obesity, regardless of ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.

“Almonds are a great source of healthy fats, fiber, and magnesium, all of which can contribute to fat loss and muscle recovery,” says Manaker. “Magnesium, in particular, helps relax your body and ...

First, the stock has sliced through two support levels. Shares broke through their 50-day moving average on Monday for the ...

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...